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Abstract
Membrane proteins are involved in a wide variety of cellular processes, and are typically part of the first
interaction a cell has with extracellular molecules. As a result, these proteins comprise a majority of known
drug targets. Membrane proteins are among the most difficult proteins to obtain and characterize, and a
structure-based understanding of their properties can be difficult to elucidate. Notwithstanding, the design of
membrane proteins can provide stringent tests of our understanding of these crucial biological systems, as
well as introduce novel or targeted functionalities. Computational design methods have been particularly
helpful in addressing these issues and this review discusses recent studies that tailor membrane proteins to
display specific structures or functions, and how redesigned membrane proteins are being used to facilitate
structural and functional studies.
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Summary
Membrane proteins are involved in a wide variety of cellular processes, and are typically part of
the first interaction a cell has with extracellular molecules. As a result, these proteins comprise a
majority of known drug targets. Membrane proteins are among the most difficult proteins to obtain
and characterize, and a structure-based understanding of their properties can be difficult to
elucidate. Notwithstanding, the design of membrane proteins can provide stringent tests of our
understanding of these crucial biological systems, as well as introduce novel or targeted
functionalities. Computational design methods have been particularly helpful in addressing these
issues and this review discusses recent studies that tailor membrane proteins to display specific
structures or functions, and how redesigned membrane proteins are being used to facilitate
structural and functional studies.
Introduction
Residing within lipid bilayers, integral membrane proteins are ubiquitous in cells and it is
estimated that roughly 15–30% of the proteins in currently known genomes are integral
membrane proteins (Almen et al., 2009; Wallin and von Heijne, 1998). These proteins
participate in a wide diversity of cellular processes, including selective molecular transport
across the bilayer, uptake of nutrients, discharge of toxins and waste products, respiration,
cell motility, and cell signaling. Given their relevance to cellular physiology, membrane
proteins--particularly receptor proteins and ion channels--are of great significance for a wide
variety of therapeutics, with approximately 60% of currently available drugs having a
membrane protein as a target (Overington et al., 2006). In recent years, advances in their
study and characterization have furthered our understanding of the general molecular
properties and biophysical principles germane to membrane proteins, but additional work
needs to be done to acquire a detailed, predictive knowledge of the molecular basis of their
structures, stabilities, and activities (White, 2009).
In this brief review, we highlight advances toward the design and redesign of integral
membrane proteins with special emphasis on recent applications of computational methods.
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The development of approaches to engineer membrane proteins has exploited advances
involving both experimental and computational techniques. After briefly introducing some
of the major challenges in working with membrane proteins and recent advances to address
these, examples of designed membrane proteins are presented. Such designs can be used to
explore membrane protein structure, introduce new functionality, modulate membrane
integrity, control the activity of receptors and integrins, and arrive at water-soluble variants
of membrane proteins. We focus on cases where designed proteins have been characterized
experimentally.
Challenges in working with membrane proteins
Membrane proteins are notoriously difficult to study in their natural forms and are often
difficult to obtain in large quantity. Typically present in low amounts in native tissues these
proteins are difficult to isolate in quantities sufficient for detailed characterization. The
situation is rendered even more challenging due to the fact that they are also difficult to
over-express. Given that structural studies of proteins (e.g., using diffraction-quality crystals
or NMR methods) typically require large amounts (> 10 mg) of protein, it is clear that
naturally low abundances of membrane proteins in their native sources poses a significant
impediment to their detailed examination. Consequently, most membrane proteins are over-
expressed in heterologous bacterial and eukaryotic expression systems, a process with its
own obstacles. Recombinant production and/or purification of membrane proteins present
major hurdles in their study and structure determination. In this respect, eukaryotic
recombinant proteins are particularly problematic, and mammalian membrane proteins are
some of the most challenging. As a result, most membrane protein structures determined
thus far are from bacteria and archaea (Alguel et al., 2010; Bill et al., 2011).
Even when sufficiently large amounts of protein can be obtained and purified, determining
the structures of membrane proteins can be arduous. These proteins typically have low
stability in the detergents used for dispersion in aqueous media and are susceptible to
aggregation. Obtaining conditions under which such proteins can be crystallized or studied
using NMR methods can be delicate and time-intensive, often involving extensive trial and
error. Particulary elusive is obtaining quality crystals suitable for high-resolution x-ray
diffraction studies (Alguel et al., 2010; Bill et al., 2011). Despite these difficulties, a
significant number of membrane protein structures have been determined over the past 25
years. The number of nonredundant structures is currently around 300 (see (White, 2009)
and the associated online database), which is only about 2% of known protein structures
(Arinaminpathy et al., 2009). Of note, many of these membrane protein structures have been
realized as protein mutants and chimeras (Chien et al., 2010; Jaakola et al., 2008;
Rasmussen et al., 2011; Rosenbaum et al., 2007; Shimamura et al., 2011).
Significant progress in preparing membrane protein samples for structural and functional
studies has been made in recent years. Novel approaches have been developed for improving
the stability of membrane proteins and have facilitated determination of their structures.
Rapid screening assays have been used to optimize the conditions that confer stability using
GFP fusion proteins (Drew et al., 2008; Newstead et al., 2007). Complexes involving
membrane proteins and monoclonal antibody fragments can increase the effective surface
Perez-Aguilar and Saven Page 2
Structure. Author manuscript; available in PMC 2014 July 24.
area and introduce additional sites for crystal contact formation (Dutzler et al., 2003; Hunte
et al., 2000; Iwata et al., 1995; Rasmussen et al., 2007; Zhou et al., 2001). Engineered fusion
proteins have also been used in structure determination; for example a breakthrough in the
structural biology of G protein-coupled receptors (GPCRs) came when a chimera was
created that included a robust, crystal-forming protein (T4 lysozyme) and a GPCR, the
human β2 adrenergic receptor (β2-AR; (Cherezov et al., 2007; Rosenbaum et al., 2007))
resulting in a high resolution β2-AR structure. Short-chain detergents can form small
micelles that leave large hydrophilic regions exposed. These detergents can be used in
combination with thermostabilization strategies, where alanine scanning allows
identification of stabilizing mutations so as to make the protein/micelle complex stable
enough for crystallization (Lebon et al., 2011a; Lebon et al., 2011b; Magnani et al., 2008;
Serrano-Vega et al., 2008; Shibata et al., 2009; Warne et al., 2008). The development of
improved detergents has yielded stable protein-detergent micelles suitable for crystallization
(Popot et al., 2003; Yu et al., 2000). Though not specific to membrane proteins,
improvements in robotic technologies enhance both the exploration of a large number of
crystallization conditions and the collection of the X-ray diffraction data. In addition,
microfocus X-ray diffraction has the promise to reduce the necessary size of crystals
required for solving structures as well as the ability to examine different regions of the same
crystal, which may have different diffraction qualities (Bowler et al., 2010).
Design of Membrane Proteins
Structural and functional studies of nature’s membrane proteins are frontier areas of
structural biology, and a variety of beautiful structures have recently been elucidated. These
include GPCRs (Chien et al., 2010; Jaakola et al., 2008; Palczewski et al., 2000; Rasmussen
et al., 2011; Rosenbaum et al., 2007; Shimamura et al., 2011; Warne et al., 2008; Wu et al.,
2010) and pentameric ligand-gated ion channels (Bocquet et al., 2009; Hibbs and Gouaux,
2011; Hilf and Dutzler, 2008, 2009; Miyazawa et al., 2003). The natural systems are often
highly complex, however, and it is desirable to create systems where the details of function
and structure are more readily at the control of the researcher. Designing and redesigning
membrane proteins is one such route to better understand and engineer the structure and
function of membrane proteins. Such design endeavors also, provide a way to test
hypotheses concerning structure, function, and protein-protein interactions within
membranes. Successful design can lead to proteins having new or tunable properties while
residing in the membrane and facilitate studies of their functions and structures. Indeed,
many of the recent structures of eukaryotic integral membrane proteins are mutants and/or
chimeric constructs, where domains have been deleted or exogenous domains have been
added, so as to render proteins that are more readily over-expressed, more soluble, or more
likely to crystallize (Chien et al., 2010; Jaakola et al., 2008; Rasmussen et al., 2011;
Rosenbaum et al., 2007; Shimamura et al., 2011; Wu et al., 2010).
Early successful efforts in membrane protein design focused on hydrophobic patterning of
exterior residues in a manner consistent with a lipid bilayer. Synthetic α-helical amphiphilic
peptides were designed to mimic properties of protein ion channels. Comprising only
leucine and serine residues, a self-assembling 21-residue model peptide was designed to
span the membrane and form an ion channel (Lear et al., 1988). The designed oligomeric
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protein had properties similar to those of the acetylcholine receptor with regard to its
channel conductance, cation selectivity and open state lifetime (Lear et al., 1988). An
alternative peptide with one heptad position changed from serine to leucine produced a
proton-selective channel, while a shortened version with only 14 residues was too short to
span the phospolipid bilayer and failed to form discrete stable channels (Lear et al., 1988).
Another early success employed one, two and four hydrophobic transmembrane segments.
Using a highly simplified amino acid composition (mainly leucines and alanines), sequences
of the α-helical segments were tailored for efficient insertion into the inner membrane when
expressed in E. coli. The appropriate positioning of positively charged lysine residues was
found to control the overall orientation of the protein in the lipid bilayer (Whitley et al.,
1994).
Redesigned water-soluble proteins often provide a starting point for understanding the
association of proteins in membrane environments. An early model system for studying the
association of coiled-coils in aqueous media was the dimeric leucine zipper from a
eukaryotic transcriptional regulator protein, GCN4 (Harbury et al., 1993). This system
contains buried asparagine residues that mediate dimerization. The identities of surface
exposed residues of the dimer were changed from polar to apolar to create membrane-
soluble versions (Choma et al., 2000; Zhou et al., 2000). In the membrane-soluble analogs,
the same buried asparagines mediate the formation of dimer and trimers; mutation of the
buried asparagines to valines eliminated oligomerization. The oligomeric equilibrium was
modulated by modification of the relative detergent concentration, and trimer formation was
predominant at the highest peptide/detergent ratios (Choma et al., 2000). Using similar
analogs, the roles of different residues at the “a” positions (where “a” is the first position in
the heptad repeat of the coiled-coil structures) along the dimer interface were investigated
with regard to their impact on dimer stability (Zhang et al., 2009). The results reveal that the
size and hydrophobic character of the side chain regulates helix association. The helix
association propensity of amino acids can be rank ordered: Gly > Ala > Val > Ile. This
ranking is reversed relative to that observed for dimerization in water-soluble structures
(Acharya et al., 2006; Wagschal et al., 1999). These findings suggest that van der Waals and
electrostatic interactions dominate the stability and orientational preferences of the
intramembrane dimers.
The approaches described in this section used largely empirical knowledge of structure,
sequence and natural proteins to create novel membrane proteins. The work has revealed the
degree to which knowledge acquired from studies of globular proteins can be extended to
membrane proteins. Such studies also reveal features and trends that are unique to
membrane associated proteins. Protein design provides a route to probe and characterize the
biophysical principles governing protein-protein and protein-lipid interactions in membranes
and opens the potential for more detailed, challenging, and sophisticated designs.
Design of Functional Membrane Proteins
Leveraging the insight gained from studies of transmembrane helical peptides and proteins,
functionality can be introduced in to designed systems. Membrane associated proteins have
been designed to provide a “switch” that can be used to modulate the integrity of a lipid
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bilayer. In particular, amphiphilic α-helical peptides are known to be antimicrobial and to
rupture cell membranes. In this regard, mastoparan X, a natural α-helical cell-lytic peptide
has been redesigned to bind divalent cations. Upon binding of Zn(II) or Ni(II), the
amphiphilic structure of the designed peptide is stabilized, which triggers the lysis of cells
and vesicles (Signarvic and Degrado, 2009). The strategy demostrates the feasibility of
designing proteins that can be selectively triggered to disrupt membranes.
Fusion of protein domains can yield chimeras that are useful for structural studies and can
also be used to realize designed membrane proteins with targeted functionalities. One such
effort yielded a pentameric ligand-gated ion channel, where each subunit comprised a
prokaryotic extracellular domain and a eukaryotic transmembrane domain (Duret et al.,
2011). The extracellular segment of the chimera was the proton-gated ion channel from
Gloeobacter violaceus (GLIC), while the transmembrane segment was the anion-selective
human α1 glycine receptor (Figure 1). Putative mismatches at the interface between the
prokaryotic and eukaryotic domains of the chimera were minimized. The site of fusion was
carefully selected and specific interfacial motifs were switched from the extracellular
identity (GLIC) to the transmembrane identity (α1 glycine receptor). The chimera functions
as a proton-gated ion channel, as evidenced from electrophysiological data obtained in
Xenopus oocytes. Moreover, using patch-clamp experiments in baby hamster kidney (BHK)
cells it was shown that the chimera displays anion selectivity identical to that of the glycine
receptor. The activity of the chimera does not require posttranslational modifications typical
of eukaryotic extracellular domains, and therefore the protein is good candidate for bacterial
expression systems. This work provides a starting point for studies of the coupling between
ligand gating and ion channel activity, as well as drug development; the findings suggest
that GLIC and α1 glycine receptors may possess highly similar structures.
Another example of creating functional membrane proteins was based on a natural
transmembrane dimer motif. Using the structure of the transmembrane region of
glycophorin A, a bis-histidine binding site was designed to bind the cofactor Fe-
protoporphyrin IX (Cordova et al., 2007). Five out of 32 transmembrane residues were
modified, and the resulting structure was characterized in dodecylphosphocholine (DPC)
micelles (Figure 2). The protein binds the cofactor with submicromolar affinity and retains
the dimeric oligomerization state. Moreover, the catalytic activity of the complex was
characterized by the oxidation of the organic substrate TMB (2,2′,5,5′ -tetramethyl-
benzidine). TMB undergoes two successive oxidations in the presence of peroxide to
produce TMB-ox, and formation of the latter indicated that the complex presents modest
peroxidase activity. A single mutation (G25F) was introduced to assess aromatic-porphyrin
interactions. The mutant binds heme with a lower dissociation constant (by a factor of 1/10),
displays a change in the midpoint potential, and presents a decrease in peroxidase activity.
The changes were ascribed to the stabilization of the Fe(III) form in the mutant. The
findings illustrate the use of designed proteins to control the properties of the porphyrin
cofactor within a membrane localized environment.
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Computational Design of Membrane Proteins
The design efforts described thus far draw heavily upon structures and sequences derived
from natural membrane proteins and/or qualitative and coarse-grained representations of
protein sequence and structure (e.g., hydrophobic patterning). The interactions within a
structured protein can have many levels of complexity, and often more molecular detail is
required to specify structure and activity. Atomistic approaches to design are potentially
more powerful and versatile, particularly when large numbers of candidate sequences are
possible. Nature uses variation of sequence and selection to arrive at proteins with precisely
tuned structures and functionalities. In the laboratory, well-folded proteins can potentially be
identified through the careful choice of sequences, but this choice can be nontrivial. Proteins
contain tens to thousands of amino acid residues, and even for a single sequence, many
conformations of the backbone are possible. Even if we consider just a single backbone
tertiary structure, exponentially large numbers of side chain conformations are possible. In
addition, the folded states of proteins are stabilized largely by noncovalent forces: van der
Waals, hydrophobic, electrostatic, and hydrogen-bonding interactions. Given the subtlety of
these interactions, reliable estimates of stability with respect to unfolding can be difficult to
calculate using molecular modeling methods. Furthermore, the large numbers of potential
sequences can lead to combinatorial complexity in protein design: using just the 20 naturally
occurring amino acids, a small protein of only 100 amino acids has more than 10130 possible
sequences.
To address many of these difficulties, computational methods have been developed for the
design of proteins. Most methods take as input a target structure, which can be a natural one
or one created de novo via computational modeling. Energy-based objective functions are
used to quantify interactions within a given structure and assess the compatibility between
potential sequences and targeted structures and functions. The methods can identify
individual sequences or the properties of sequences in an ensemble likely to possess targeted
structural and functional properties. Optimization-based methods for identifying such low-
energy sequences employ algorithms such as pruning methods (dead-end elimination)
(Desmet et al., 1992) (Dahiyat and Mayo, 1997), Monte Carlo simulated annealing (Hellinga
and Richards, 1994; Shakhnovich and Gutin, 1993) (Kuhlman and Baker, 2000), and genetic
algorithms (Butterfoss and Kuhlman, 2006; Desjarlais and Handel, 1995; Kang and Saven,
2007; Samish et al., 2011; Saven, 2011). Such methods identify low-energy sequences.
Alternatively, probabilistic methods characterize an ensemble of sequences and use methods
derived from statistical thermodynamics to estimate the site-specific probabilities of the
amino acids at variable sites within the protein (Calhoun et al., 2003; Kono and Saven,
2001; Park et al., 2005; Samish et al., 2011; Yang and Saven, 2005). Computational protein
design may be used to design novel nonbiological protein-based molecular systems, to better
understand protein stability and folding, and to facilitate the study of natural proteins.
The computational design of water-soluble proteins has seen significant progress (Nanda
and Koder, 2010; Samish et al., 2011; Saven, 2011) and has been extended to the design of
membrane proteins recently. Many of the biophysical principles involved in protein/protein
and protein/membrane interactions within the anisotropic environment of the lipid bilayer
are at least partially understood. Leveraging this understanding, particularly with the
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assistance of computational design methods, stands to open new routes to the design and
investigation of membrane proteins. Excellent related reviews of membrane protein design
have also recently appeared (Ghirlanda, 2009; Senes, 2011).
In applying computational protein design, the features and structures that are specific to
membrane proteins must be identified and quantified. Though they often have well-packed
hydrophobic interiors, membrane proteins also have features that are distinct from water-
soluble proteins. Efforts have been made to discern and characterize transmembrane helix-
helix interaction motifs (Walters and Degrado, 2006). Energy functions have been
developed based upon the observed frequencies with which the amino acids reside in
particular regions of the lipid bilayer, and these depth-dependent propensities have been
parameterized so as to reproduce the observed positioning of amino acids in helical
transmembrane proteins (Senes et al., 2007). Relevant to membrane protein design is work
involving the modeling and computational analysis of membrane protein structures,
particularly with an eye toward structure prediction (Barth et al., 2007). Adjustments to
energy functions developed for soluble proteins have been performed using a set of 18 high-
resolution crystal structures of membrane proteins (Barth et al., 2007). Features frequently
observed in membrane proteins were included explicitly: a membrane depth-dependent term
for the amino acids and a bifurcated hydrogen bond term in which a carbonyl oxygen
accepts more than one hydrogen bond. Furthermore, a weak Cα-H hydrogen bond with a
carbonyl group was also considered. Such Cα-H interactions have been observed in
transmembrane helices and suggested to stabilize helix-helix interactions (Bowie, 2011;
Senes et al., 2001). The results obtained using proteins of less than 150 residues displayed
an accuracy of structure prediction quantified by an RMSD < 2.5 Å when the model is
compared to the known crystal structure (Barth et al., 2007). The method was extended to
larger proteins (ranging between 190 and 300 residues) with the addition of experimental
constraints on the structure (Barth et al., 2009). The constraints were extracted mainly from
helix-helix packing arrangements, from a library of 79 high-resolution membrane proteins,
cofactor vicinity geometries, and mutagenesis information.
Computational de novo protein design has been used to explore the residues involved in
dimerization of GPCRs. Computational methods were used to identify 3–5 mutations at the
putative dimer interface of rhodopsin. The predicted effects of mutations on the
oligomerization state were consistent with experimentally derived mutation and alanine
scanning data. The results suggest computational design and provide powerful tools for
exploring the role of oligomerization in these important receptor proteins (Taylor et al.,
2008).
Water-soluble proteins have been designed to selectively bind nonbiological porphyrin-
based cofactors (Bender et al., 2007; Cochran et al., 2005; Fry et al., 2010; McAllister et al.,
2008), and one of these complexes has been redesigned to yield a redox-active membrane
protein (Korendovych et al., 2010). This membrane protein (PRIME) was designed to form
an antiparallel D2 symmetric homo-tetramer. The 24-residue helix bundle contains two bis-
histidine binding sites that accommodate two nonbiological iron diphenylporphyrin
cofactors (FeIIIDPP), which are poised to form a multicentered pathway for transmembrane
electron transfer (Figure 3). Using threonine residues, an interhelical second-shell hydrogen
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bond was designed to stabilize and orient the metal-coordinating histidine residues (Cochran
et al., 2005; Korendovych et al., 2010). The stability of the complex derives from
complementary van der Waals interactions throughout the interior, designed bis-his cofactor
coordination, and His-Thr hydrogen bonding between helices (Cochran et al., 2005;
Korendovych et al., 2010). The energies for the designed membrane protein were scored
using the CHARMM potential with an implicit membrane solvation model (Lazaridis,
2003). The suitability of the sequence was assessed from calculations using a statistical
potential (EZ) based upon the observed positioning of amino acids within the lipid bilayer
(Senes et al., 2007). The designed membrane protein PRIME displays specificity for the
FeIIIDPP cofactor and has the expected stoichiometry. The CD spectra are consistent with
the targeted helical structure and orientation of the cofactors. The measured reduction
potentials (E1/2) are consistent with the target structure, and the difference in E1/2 for
reduction of the first and second FeIIIDPP is similar to that measured for natural four-helix/
bis-Fe-porphyrin proteins. This study establishes that guiding principles used for the design
of soluble proteins, e.g., complementary van der Waals interactions and metal ion
coordination, can be augmented to include features specific to membrane proteins to arrive
at designed transmembrane complexes containing nonbiological redox-active cofactors.
Computational design has been used to examine the role of cooperative interactions between
residues in a serine-zipper transmembrane helix motif. A probabilistic method was used to
partially design sequences for a pair of associating helices. The designed protein forms a
parallel helix dimer, but mutation of the central serine residues to alanines yields dimers of
comparable stability, suggesting that complementary van der Waals interactions rather than
hydrogen bonding plays a dominant role in stabilizing the dimer (North et al., 2006).
Leveraging the expertise gained from studying transmembrane proteins, it is possible to
design transmembrane proteins that modulate the activities of the natural ones. Helical
peptides have been designed that associate with the transmembrane domains of integrins and
modulate their functions using a computational method (CHAMP: Computed Helical Anti
Membrane Protein) (Yin et al., 2007). The native activity of the human integrins αIIbβ3 and
αvβ3 is modulated by association of the helical transmembrane domains of the α and β
subunits. Together with interaction of their cytoplasmic domains, the interaction of the
transmembrane helices stabilizes the inactive state, whereas stimulation by an agonist such
as adenosine 5′ -diphosphate (ADP) shifts the integrin to an active state. The interaction of
the transmembrane domains of the integrin αIIbβ3 with a peptide from the transmembrane
domain of αIIb (αIIb–TM) induces platelet aggregation and yields dissociation of the α and β
heterodimer (Yin et al., 2006). This information was used to guide the identification of
peptides that selectively recognize the transmembrane domains of αIIb and αv (Yin et al.,
2007). The sequence of the target transmembrane domains of αIIb and αv were compared to
existing structural motifs. A suitable backbone geometry was identified from a library of
structurally defined helix pairs that were already local minima with respect to interhelical
backbone-backbone interactions. This transmembrane structure and sequence of αIIb on one
(integrin) helix provided a “mold” for design of a second helix, the CHAMP peptide.
Complementary van der Waals interactions were obtained by designing the sequence using a
Monte Carlo algorithm. The calculations used energies derived from van der Waals
interactions and a statistical potential for transmembrane orientation (EZ potential (Senes et
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al., 2007)). The residues residing in the lipid interior were restrained to the amino acids most
frequently found in transmembrane helices (G, A, V, I, L, S, T, and F). The resulting anti-
αIIb and anti-αv peptides (Figure 4) recognize their targets with high specificity and formed
heterodimers in micelles. Moreover, the anti-αIIb and anti-αv peptides strongly activated
αIIbβ3 and αvβ3 in mammalian cells, resulting in platelet aggregation (αIIbβ3) or adhesion
(αvβ3). Despite the similarity of these integrins and of the templates used, cross-reactivity of
the designed peptides was not observed. Lastly, the roles of the GxxxG-like motif (Russ and
Engelman, 2000), complementary van der Waals interactions, and the Cα-H hydrogen
bonding with a carbonyl group (Senes et al., 2001) were suggested as major driving forces in
the selective association of the transmembrane helices. The approach has been further
validated in studies of the direct interaction of the designed anti-αIIb CHAMP peptide with
isolated full-length integrin αIIbβ3 in detergent micelles. The designed peptides assume
αhelical conformations that span the membrane and do not disrupt the bilayer integrity
(Caputo et al., 2008).
The structure determination and functional characterization of membrane proteins remain
challenging. Much of the difficulty arises from the poor expression level and poor solubility
of the typical membrane protein. As a result, a variety of cell free, prokaryotic and
eukaryotic over-expression systems are commonly employed to generate proteins in
sufficiently large amounts, and then surfactants or co-proteins are employed to disperse, and
when possible, crystallize the protein. Such efforts to realize large quantities of a membrane
protein in a form suitable for structural studies are time-intensive and often involve
extensive trial and error.
An alternative approach is to redesign a membrane protein as a water-soluble variant, while
retaining the overall structure and many of the functionally related properties, e.g., ligand
binding. Soluble proteins are usually much easier to obtain in large quantity, purify and
analyze structurally. Transmembrane proteins have large numbers of exterior hydrophobic
residues that complement the hydrophobic character of the bilayer interior. For many
membrane proteins, the interior of the protein structure is similar to that of a typical water-
soluble protein, in that it has large numbers of complementary hydrophobic residues. The
solubilization approach focuses on redesigning the hydrophobic exterior transmembrane
positions of the protein. Using computational design, water-soluble variants of
transmembrane proteins have been designed, providing a proof of principle for the creation
of variants that facilitate structural and functional studies (Bronson et al., 2006; Slovic et al.,
2004). An initial target was the bacterial potassium ion channel KcsA, specifically the
tetrameric integral membrane region (Zhou et al., 2001). The computationally designed
water-soluble variant contains 29 designed exterior mutations in each of the four 104-
residue subunits of the transmembrane domain. The protein was redesigned using a
probabilistic design method so as to have exterior residues in the transmembrane domain
that are consistent with each other and with those expected on the surface of a water-soluble
protein (Slovic et al., 2004). The site-dependent probabilities of the amino acids at variable
exterior positions were determined using a molecular potential (Amber) and an
environmental energy (solvation propensity) for the amino acids that was tuned to a value
consistent with that observed among soluble proteins of similar size. The designed proteins
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express in large yield in E. coli, and one designed variant forms predominantly the target
tetramer in solution. This protein (WSK-3) binds an ion channel toxin with the
stoichiometry and affinity of the wild type protein. The solution structure of WSK-3 has
been determined using NMR methods (Ma et al., 2008). The tertiary and quaternary
structures are in excellent agreement with those from the X-ray crystallographic structure of
the membrane-soluble wild-type protein (Figure 5) (Ma et al., 2008; Zhou et al., 2001). As
expected, the water-soluble form exhibits larger structural fluctuations than the membrane
bound form (Bronson et al., 2006; Ma et al., 2008). The chemical shifts of the residues
bordering the selectivity filter of the protein are highly sensitive to potassium ion
concentration, consistent with their native functional significance. The study suggests that
identification of water-soluble variants of membrane proteins for biophysical, functional,
and structural studies may be achieved via the computational redesign of sequence.
A similar solubilization approach was applied to obtain water-soluble variants of the
transmembrane domain of the α1 subunit from a nicotinic acetylcholine receptor (nAChR), a
eukaryotic pentameric ligand-gated ion channel (Cui et al., 2012). Using the transmembrane
domain of the α1 subunit from the cryo-EM structure from Torpedo nAChR as template
(Miyazawa et al., 2003), 23 exposed hydrophobic residues were computationally redesigned.
To express the designed protein as a single chain, a polyglycine linker was used to connect
the TM4 helix with a fragment containing the other three helices. The designed sequence
(WSA) was expressed in E. coli, and its NMR structure was determined. The structure of
WSA displays the expected four-helix bundle topology, but a detailed structural comparison
indicates that the WSA structure resembles more the structure seen in GLIC, a prokaryotic
homolog, than that in the original template structure. This was somewhat surprising, since
the sequence of WSA is more similar to the wild-type transmembrane domain of nAChR
(~83%) than to the transmembrane domain of GLIC (~11%). In addition, anesthetic binding
studies in WSA showed excellent agreement with the binding site identified in the recent co-
crystal structures of GLIC with similar general anesthetics (Nury et al., 2011). This result
indicates that the designed water-soluble analogs retain the putative binding sites and thus,
they could serve as good surrogates of membrane proteins for drug screening. Also, to
disperse WSA at pH values suitable for NMR studies, 2% of LPPG detergent was utilized.
Based on inter-molecular NMR cross-peaks, WSA-detergent interactions were identified
and compared with the positions of lipid molecules present in the GLIC structure (Bocquet
et al., 2009; Hilf and Dutzler, 2009). The location of the interaction site of WSA-LPPG is in
excellent agreement with the location of the lipid in GLIC. These findings further support
the notion that the designed water-soluble variants are able to retain important features of
the structure, function and intermolecular interactions of their parent wild type membrane
proteins.
Application of computational approaches in membrane protein design has established
flexible, formal and physically grounded protocols to address the subtle interactions present
in membrane proteins while exploring new functionalities such as the regulation of integrin
activity. The examples described in this section exemplify the power and tunability of
computational approaches. Additionally, the strategy involving membrane protein
solubilization by redesign is supported by the two successful studies; these findings point to
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the potential of using this approach to obtain proteins in large quantity in forms suitable for
biophysical, ligand-binding, and structural studies.
Conclusions and outlook
Membrane protein design provides new routes to explore the structures and functions of
these important but recalcitrant proteins, particularly when such design efforts are assisted
by computational methods. Design can provide routes to novel proteins that can introduce
new functions to membranes and modulate their integrity. Designed proteins can be conduits
for transmembrane flow of ions, electrons, small molecules and (in the case of signaling)
information. Furthermore, designed proteins can also be used to modulate the functional
properties of membrane associated proteins, as in the case of transmembrane helical peptides
targeted to the transmembrane domains of specific integrins. Some of the long-standing
problem areas in structural biology are the difficulties associated with structural and
functional studies of membrane proteins from a molecular perspective. The redesign of
natural membrane proteins to facilitate their study—including removing them from the
membrane altogether in the form of water-soluble proteins—provides a promising route to
obtain protein in large quantities and explore functions and structures. Such studies have
obvious relevance to drug development. Computationally guided protein design stands to
make studies of membrane proteins more informative and effective. The design of proteins
having the complexity, efficiency and specificity of nature’s proteins is likely to remain
challenging, but combining computational design and experimental studies will advance our
abilities to engineer novel proteins, control biological activity, and better understand the
natural systems. Incorporating nonnatural functions and components, e.g., nonbiological
amino acids and cofactors, will yield protein-based systems that have properties not
available in nature. Perhaps most importantly, attempts to design novel membrane proteins
will provide stringent assessments of our understanding of the important structural,
energetic, and functional features of these vital molecular systems.
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Highlights
• Computational design methods have advanced our capability to design
membrane proteins.
• Designed membrane proteins bring new functionality to membranes and
regulate lipid bilayer integrity.
• Designed proteins can regulate the activity of natural membrane proteins such as
integrins.
• Designed water-soluble variants facilitate structural and functional studies of
integral membrane proteins.
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Figure 1. Pentameric Ligand-Gated Ion Channel Chimera
Rendering of the chimera membrane protein structure based on the structure of GLIC (pdb
accession code: 3EHZ). The extracellular domain (yellow) is from the prokaryotic proton-
gated ion channel GLIC and the transmembrane domain (blue) is from eukaryotic anionic-
selective α1 glycine receptor (Duret et al., 2011). Small modifications at the interface of the
two domains are colored in magenta and orange. For clarity, the other subunits are colored
gray.
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Figure 2. Structure of the Redesigned Glycophorin A in Complex with the Cofactor
Protoporphyrin IX
The designed bis-histidine binding site is depicted together with the protoporphyrin IX
ligand (Cordova et al., 2007). The modified positions in the structure of glycophorin A are
colored in blue.
Perez-Aguilar and Saven Page 19
Structure. Author manuscript; available in PMC 2014 July 24.
Figure 3. Topology of the De Novo Designed Membrane Protein PRIME
The de novo designed membrane protein PRIME is depicted with two nonbiological iron
diphenylporphyrin (FeIIIDPP) cofactors (in blue) (Korendovych et al., 2010). The cofactor
binding site is displayed in more detail showing the axial interaction of the histidine residue
and the iron metal. The second-shell hydrogen bond with threonine residue is also indicated.
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Figure 4. CHAMP Transmembrane Peptides
Structural models of the CHAMP transmembrane peptides (blue) designed to bind (yellow)
αIIb (right panel) and (yellow) αv (left panel) integrins with high specificity–both
transmembrane motifs naturally bind integrin β3 (Yin et al., 2007). The GxxxG motif is
highlighted with space-filling representations in both cases.
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Figure 5. Transmembrane Portion of the Bacterial Potassium Ion Channel KcsA and its Water-
soluble Variant
Comparison of the structure of the bacterial potassium ion channel KcsA (yellow) (pdb
accession code: 1K4C) (Zhou et al., 2001) and its water-soluble variant (blue) (pdb
accession code: 2K1E) (Ma et al., 2008). The water-soluble variant was expressed in E. Coli
and contains 29 computationally designed exterior mutations in each of the four 104-residue
subunits. Depicted as orange spheres in the water-soluble structure (blue), are the Cα atoms
for the exterior positions that were computationally designed (Slovic et al., 2004). In the
right image all four subunits are depicted while in the left image (side view) only two
subunits are rendered.
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Figure 6. Cryo-EM Structure of a Transmembrane Domain from the Nicotinic Acetylcholine
Receptor, NMR Structure of its Water-Soluble Analog (WSA) and X-ray structure of the
Prokaryotic Homolog GLIC
Comparison of the 4-Å-resolution cryo-EM structure of the transmembrane domain of the
α1 subunit from the nicotinic acetylcholine receptor (gray) (pdb accession code: 1OED)
(Miyazawa et al., 2003), the NMR structure of a water-soluble analog from the same
segment (blue) (pdb accession code: 2LKG) (Cui et al., 2012), and transmembrane domain
of the prokaryotic homolog GLIC (yellow) (pdb accession code: 3EAM) (Bocquet et al.,
2009). The water-soluble variant was expressed in E. Coli and contains 23 computationally
designed exterior mutations (Cα atoms of these positions are depicted as orange spheres).
To link the TM4 helix with the rest of the bundle, a polyglycine linker was inserted
(magenta). Based on photoaffinity labeling studies, V31 (colored in green) was identified as
potential binding site in WSA for general anesthetics (azi-propofol and azi-isoflorane). For
comparison, the residues forming the anesthetic binding site in the co-crystal structure of
GLIC (Nury et al., 2011) are shown in sticks representations.
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